It is a pharma private limited company based in Ambala City, Haryana, India, established in 2018.
2018 | Ambala City, Haryana, India | ActiveEishlon Pharmacon Private Limited, a active private limited company, was established on 20 February 2018 in Ambala City, Haryana, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U74999HR2018PTC072646. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹7.50 M and a paid-up capital of ₹7.50 M.
It upholds a compliant status. Its leadership includes Ashok Kumar (Director), Ankit Agrawal (Director), Preeti Agrawal (Director). Past directors included Ronit Kumar, Usha Agrawal, Anand Khaitan. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Shop No. 45 Vita Enclave, Ambala City, Haryana, 134003.
U74999HR2018PTC072646
072646
20 February 2018
₹7.50 M
₹7.50 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Eishlon Pharmacon Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ashok Kumar | Director | 13 Aug 2018 | Current |
| Ankit Agrawal | Director | 20 Feb 2018 | Current |
| Preeti Agrawal | Director | 17 Sep 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 07 Jul 2025 | Past |
| Pramod Abcsdd | Director | 07 Jul 2025 | Past |
| Pramod Abcsdd | Director | 13 Jul 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Eishlon Pharmacon Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 7.57% increase. The company also saw a substantial fall in profitability, with a 81.53% decrease in profit. The company's net worth moved up by a moderate rise of 0.91%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Eishlon Pharmacon's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Eishlon Pharmacon, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Eishlon Pharmacon, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eishlon Pharmacon's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Eishlon Pharmacon Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Eishlon Pharmacon Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
Progress on Preeti Agrawal was appointed as a Director was appointed as a Director on 17 Sep 2018 & has been associated with this company since 7 years 2 months . was documented.
The activity Ashok Kumar was appointed as a Director was appointed as a Director on 13 Aug 2018 & has been associated with this company since 7 years 3 months . was completed.
The activity Ankit Agrawal was appointed as a Director was appointed as a Director on 20 Feb 2018 & has been associated with this company since 7 years 9 months . was completed.
Progress on Eishlon Pharmacon Private Limited was registered on 20 Feb 2018 with Roc Delhi & aged 7 years 9 months as per MCA records. was documented.
The CIN of Eishlon Pharmacon Private Limited is U74999HR2018PTC072646.
Eishlon Pharmacon Private Limited is headquartered at Shop No. 45 Vita Enclave, Ambala City, Haryana, 134003.
Eishlon Pharmacon Private Limited was incorporated on 20 February 2018.
The current directors of Eishlon Pharmacon Private Limited are
The primary industry of Eishlon Pharmacon Private Limited is Trade.
Eishlon Pharmacon Private Limited is unlisted.
The authorized capital of Eishlon Pharmacon Private Limited is ₹7.50 M, and the paid-up capital is ₹7.50 M.
The compliance status of Eishlon Pharmacon Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX